Endonovo Therapeutics Inc. has arranged an equity purchase agreement with Cavalry Fund I, under which Endonovo will sell up to $10 million in shares during the next 24 months, the company announced Tuesday....

Join our Membership to get the full story.


Are you a current Member? Sign In